Gilenya (fingolimod): Reviews and patient testimonials
Back to the list of medications
Medication indications
Gilenya 0.5mg hard capsules
Gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following adult patient groups:
- Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4.4 and 5.1).
or
- Patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.
Route of administration: Oral
Molecule: fingolimod
Patients' opinions on Gilenya
Conditions related to this medication
Fact sheet
See the fact sheet
Tips and advice of the community